8-K - Xenon Pharmaceuticals Inc. | StockGist

Current Report Details

Event Type

Other Event

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

Other Events On February 27, 2026, Xenon Pharmaceuticals Inc. (the “Company”) filed a prospectus supplement (the “Prospectus Supplement”) with the Securities an

Other Event

9.01

Financial Statements and Exhibits (d) Exhibits. Exhibit Number Description 5.1 Opinion of Blake, Cassels & Graydon LLP. 23.1 Consent of Blake, Cassels & Graydon

Exhibits Only

Exhibits (2)

5.1

EX-5.1

8-K